NAU JEFFREY (President and CEO) reported 1 transaction at OYSTER POINT PHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 12/5/2022ACC: 0001209191-22-059794
DirectorOfficer· President and CEO
Since Oct 2019
-6.22K
Net shares
Net seller
$69.6K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
6.22K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−6.22K
Price / share
$11.20
Trade value
$69.63K
% of position
3.9%
12/1/2022
157.60K→151.38K
Total
Net shares
−6.22K
Net value
-$69.63K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/1/2022 | F · Tax Withholding | −6.22K | $11.20 | $69.63K | 3.9% | 157.60K | 151.38K |
| Total | −6.22K | -$69.63K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1K
Total
1K indirect1K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1K | Indirect |
| Total | 1K | 1K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported